Primary Objective: To assess clinical complete response of an organ preservation approach using short course radiation followed by intensified chemotherapy.
Secondary Objective: To assess safety in all enrolled patients, local regrowth rate and other cancer specific outcomes (metastasis-free survival, colostomy-free survival and overall survival), longitudinal health-related quality of life of this organ preservation approach

